Clinical Trial Update: Antidepressants Trial in Parkinson's Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating antidepressants for depression in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Parkinson Disease

Snippet

Sponsor: University College, London | Conditions: Depression, Parkinson Disease | Phase 3 | Status: COMPLETED